GHK-Cu for skin, BPC-157 for recovery) have research behind them, but results vary and evidence is still evolving
We used a Mendelian randomization design to test whether this relation might be causal
is a co-inventor on intellectual property owned by Indiana University and licensed to Novo Nordisk, and was recently employed by Novo Nordisk and, previously, Lilly Research Laboratories
Frontiers in Neuroscience, 4
You can spray together or take separately throughout the day, but you may find it more convenient to take all together
It has numerous benefits, including better patient compliance, bypassing the first pass effect, ensuring controlled rate of drug release, and allows to swiftly halt or terminating the treatment, if required